Off-Label Promotion: FDA Commissioner's Concerns Stem From Ethics Of Informed Consent
This article was originally published in The Pink Sheet Daily
Executive Summary
'My personal view is that companies controlling that information is not the ideal,' Robert Califf tells BIO. 'That doesn’t mean I’ll carry the day.'